5 June 2026 · 51 min
With Joe Betts-LaCroix · Hosted by Julian Issa
Joe Betts-LaCroix and Retro Biosciences recently raised funding at a $1.8 billion valuation. In his first podcast appearance since the announcement, Joe shares his vision for extending healthy human lifespan and the breakthroughs driving the longevity industry forward.
JUMP INTO THE CONVERSATION
Joe Betts-LaCroix and Retro Biosciences recently raised funding at a $1.8 billion valuation. In his first podcast appearance since the announcement, Joe shares his vision for extending healthy human lifespan and the breakthroughs driving the longevity industry forward.
Joe Betts-LaCroix explains why aging is becoming a legitimate scientific target. He shares how new discoveries are turning longevity from speculation into measurable biology.
The conversation explores how AI is accelerating research, while highlighting why biology remains one of the hardest problems to solve. Even with smarter models, real-world testing and clinical trials still take time.
· 70 min
Longevity Isn’t Just About You | Tina Woods & Peter Ward on Healthspan for All #longevity #healthspan #humanexposome #aihealth #collectivehealth
Explore conversation
· 14 min
What if the Singularity isn’t coming but already here?
Explore conversation
· 64 min
What’s the biggest problem in longevity today: bad science, hype, or misplaced optimism?
Explore conversation